<Record>
<Term>Recombinant Fowlpox-B7.1 Vaccine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Virus</SemanticType>
<ParentTerm>Fowlpox Virus Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Fowlpox Virus Vaccine/Recombinant Fowlpox-B7.1 Vaccine</ClassificationPath>
<BroaderTerm>Recombinant Fowlpox-B7.1 Vaccine</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Fowlpox Virus Vaccine</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Recombinant Fowlpox-B7.1</Synonym>
<Synonym>Recombinant Fowlpox-B7.1 Vaccine</Synonym>
<Synonym>rF-B7.1</Synonym>
<Synonym>rF-B7.1 Vaccine</Synonym>
<Description>A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
